On February 27, 2008, the Tarrytown, New York-based Regeneron Pharmaceuticals received ... and ACZ 885 (canakinumab), a fully humanized monoclonal antibody directed at IL-1β, from Novartis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback